Don’t miss the Hot Topics Session – ESICM Lives 2019! Dr Jean-Baptiste LASCARROU (Nantes, FRANCE) will report study results live in BERLIN during the next ESICM congress (Lives 2019).
Hyperion was an open-label randomized controlled trial comparing moderate therapeutic hypothermia (33°C during the first 24 hours) to targeted normothermia (37°C) in comatose patients admitted to intensive care units after resuscitation from cardiac arrest with nonshockable rhythm. The primary outcome was survival with a favorable neurological outcome, assessed on post-randomization day 90 using the CPC scale. A favorable neurological outcome was defined as CPC 1 or 2. Between January 2014 and January 2018, 584 patients were included and results will be release at ESICM 2019 during the hot topic session.
A conference dedicated to anyone passionate about resuscitation and the chain of survival (paramedics, physicians, students…) with experts from around the world Join the upcoming Resuscitation Conference Paris 14 & 15 October 2019.
Second AfterROSC Working Group meeting took place in Paris on 16 Mai 2019.
Structuring of our network was concretized by the creation of a regulatory associative structure entitled AfterROSC. This organization will make our collaboration a reality, ensure promotion and support, in order to give shape to our projects!
Thus, AfterROSC network decided to quickly implement its projects by promoting its first collaborative research as a prospective observational study dealing with the evaluation of diagnostic accuracy of various prognosis scores after cardiac arrest.